Algert Global’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.59M | Buy |
9,945
+925
| +10% | +$593K | 0.08% | 410 |
|
|
2025
Q4 | $6.1M | Buy |
9,020
+8,333
| +1,213% | +$5.67M | 0.1% | 362 |
|
|
2025
Q3 | $439K | Buy |
+687
| New | +$417K | 0.01% | 940 |
|
|
2025
Q2 | – | Sell |
-11,063
| Closed | -$4.65M | – | 1247 |
|
|
2025
Q1 | $4.65M | Buy |
11,063
+950
| +9% | +$413K | 0.11% | 302 |
|
|
2024
Q4 | $4.18M | Buy |
10,113
+942
| +10% | +$413K | 0.1% | 343 |
|
|
2024
Q3 | $4.63M | Buy |
9,171
+8,462
| +1,194% | +$4.11M | 0.12% | 280 |
|
|
2024
Q2 | $345K | Buy |
709
+292
| +70% | +$147K | 0.01% | 1062 |
|
|
2024
Q1 | $225K | Sell |
417
-870
| -68% | -$475K | 0.01% | 947 |
|
|
2023
Q4 | $714K | Buy |
1,287
+632
| +96% | +$297K | 0.03% | 709 |
|
|
2023
Q3 | $286K | Sell |
655
-1,784
| -73% | -$890K | 0.01% | 904 |
|
|
2023
Q2 | $1.23M | Buy |
2,439
+140
| +6% | +$67.1K | 0.05% | 585 |
|
|
2023
Q1 | $1.15M | Sell |
2,299
-1,136
| -33% | -$544K | 0.05% | 592 |
|
|
2022
Q4 | $1.4M | Buy |
3,435
+145
| +4% | +$56.3K | 0.08% | 429 |
|
|
2022
Q3 | $1.07M | Buy |
3,290
+34
| +1% | +$12.5K | 0.06% | 510 |
|
|
2022
Q2 | $1.14M | Buy |
3,256
+543
| +20% | +$221K | 0.09% | 410 |
|
|
2022
Q1 | $1.48M | Sell |
2,713
-394
| -13% | -$207K | 0.1% | 350 |
|
|
2021
Q4 | $2.05M | Buy |
3,107
+75
| +2% | +$47.1K | 0.26% | 72 |
|
|
2021
Q3 | $1.89M | Buy |
3,032
+169
| +6% | +$114K | 0.25% | 63 |
|
|
2021
Q2 | $1.81M | Sell |
2,863
-317
| -10% | -$175K | 0.61% | 38 |
|
|
2021
Q1 | $1.56M | Sell |
3,180
-1,860
| -37% | -$932K | 0.5% | 49 |
|
|
2020
Q4 | $2.52M | Sell |
5,040
-406
| -7% | -$182K | 0.72% | 21 |
|
|
2020
Q3 | $2.14M | Sell |
5,446
-394
| -7% | -$146K | 0.68% | 33 |
|
|
2020
Q2 | $1.93M | Buy |
5,840
+347
| +6% | +$100K | 0.65% | 28 |
|
|
2020
Q1 | $1.33M | Sell |
5,493
-3,941
| -42% | -$1.03M | 0.56% | 38 |
|
|
2019
Q4 | $2.46M | Hold |
9,434
| – | – | 0.74% | 25 |
|
|
2019
Q3 | $2.56M | Hold |
9,434
| – | – | 0.96% | 15 |
|
|
2019
Q2 | $2.6M | Buy |
9,434
+4,776
| +103% | +$1.18M | 0.96% | 14 |
|
|
2019
Q1 | $1.04M | Sell |
4,658
-10,125
| -68% | -$2.09M | 0.6% | 46 |
|
|
2018
Q4 | $2.75M | Sell |
14,783
-495
| -3% | -$101K | 0.77% | 27 |
|
|
2018
Q3 | $3.81M | Sell |
15,278
-279
| -2% | -$67.7K | 0.82% | 19 |
|
|
2018
Q2 | $3.39M | Buy |
15,557
+13,271
| +581% | +$2.73M | 0.7% | 32 |
|
|
2018
Q1 | $438K | Sell |
2,286
-91
| -4% | -$16.8K | 0.08% | 262 |
|
|
2017
Q4 | $372K | Sell |
2,377
-598
| -20% | -$94.1K | 0.09% | 242 |
|
|
2017
Q3 | $463K | Sell |
2,975
-10,935
| -79% | -$1.73M | 0.11% | 232 |
|
|
2017
Q2 | $2.25M | Buy |
+13,910
| New | +$2.26M | 0.63% | 43 |
|
|
2016
Q4 | – | Sell |
-24,846
| Closed | -$2.8M | – | 371 |
|
|
2016
Q3 | $2.8M | Buy |
+24,846
| New | +$2.62M | 0.81% | 15 |
|
Other funds holding IDXX
VCM
VPM
Algert Global's IDXX Position: Q1 2026 in Review
Algert Global increased its Idexx Laboratories (IDXX) stake by 10% in Q1 2026, buying an estimated $593K and bringing the position to 9,945 shares worth $5.59M. The position accounts for 0.08% of the portfolio, ranked #410.
Algert Global first reported a position in IDXX in Q3 2016 and has held it in 36 quarters since. The position peaked at $6.1M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Algert Global held 9,945 shares of Idexx Laboratories worth $5.59M as of Q1 2026.
- Algert Global bought 925 Idexx Laboratories shares in Q1 2026, an estimated $593K.
- Idexx Laboratories made up 0.08% of Algert Global's portfolio in Q1 2026, its #410 holding.
- Algert Global first reported a position in Idexx Laboratories in Q3 2016 and has held it in 36 quarters since.
- Algert Global's Idexx Laboratories position peaked at $6.1M in Q4 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.